Investors eye Achillion for next big pharma deal
June 10, 2014 at 14:20 PM EDT
Achillion's been a takeover target for years. But Merck's acquisition of Idenix may mean Achillion's time has come.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.